Kaye Jack

Avg. Two Year Performance

520% Avg. Purchase Return
149% Compound
(7%) Avg. Sale Return
(4%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return63%103%219%480%520%
Purchase Success Rate1 of 21 of 21 of 21 of 21 of 2
Average Sale Return(8%)(9%)(16%)4%(7%)
Sale Success Rate2 of 72 of 71 of 72 of 72 of 7

Keryx Biopharmaceuticals Inc.

Drugs » Drug Manufacturers - Major

Director:

Holdings: 85.0K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Dyadic International Inc

Drugs » Biotechnology

Director:

Holdings: 33.58K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Uniqure N.V.

Drugs » Biotechnology

Director:

Holdings: 8.72K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--